相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients
Nader Sanai et al.
CLINICAL CANCER RESEARCH (2018)
Fighting tubulin-targeting anticancer drug toxicity and resistance
Roberta Visconti et al.
ENDOCRINE-RELATED CANCER (2017)
Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors
Jin-Yi Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
PLK1 Activation in Late G2 Sets Up Commitment to Mitosis
Lilia Gheghiani et al.
CELL REPORTS (2017)
Dual Targeting of WEE1 and PLK1 by AZD1775 Elicits Single Agent Cellular Anticancer Activity
Gabriela Wright et al.
ACS CHEMICAL BIOLOGY (2017)
Phase II Study of WEE1 Inhibitor AZD1775 Plus Carboplatin in Patients With TP53-Mutated Ovarian Cancer Refractory or Resistant to First-Line Therapy Within 3 Months
Suzanne Leijen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors
Suzanne Leijen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
Roberta Visconti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics
Rosie Elizabeth Ann Gutteridge et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs
R. Visconti et al.
CELL DEATH AND DIFFERENTIATION (2015)
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
Khanh Do et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Genome-wide CRISPR-Cas9 Screens Reveal Loss of Redundancy between PKMYT1 and WEE1 in Glioblastoma Stem-like Cells
Chad M. Toledo et al.
CELL REPORTS (2015)
Fcp1 phosphatase controls Greatwall kinase to promote PP2A-B55 activation and mitotic progression
Rosa Della Monica et al.
ELIFE (2015)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
Mitotic catastrophe: a mechanism for avoiding genomic instability
Ilio Vitale et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The spindle-assembly checkpoint in space and time
Andrea Musacchio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways
N Watanabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The spindle checkpoint requires cyclin-dependent kinase activity
V D'Angiolella et al.
GENES & DEVELOPMENT (2003)
Plk1 promotes nuclear translocation of human Cdc25C during prophase
F Toyoshima-Morimoto et al.
EMBO REPORTS (2002)
分享论文
